Quantitative MRI and Outcomes of Liver Resection

Not yet recruitingOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

April 30, 2025

Conditions
Liver CancerLiver FailureBile LeakLiver Metastases
Interventions
DIAGNOSTIC_TEST

Multiparametric MRI scan of the liver

MRI scans will be performed at the Champalimaud Foundation using a 1.5T scanner after patients have fasted for 4 hours. Transverse abdominal T1 maps will be acquired to estimate extracellular fluid (which increases in cases of fibrosis and inflammation) and T2\* maps will be acquired to estimate liver iron levels. These quantitative MRI maps will be laid onto the volumetric images of Couinaud segments. Multi-slice quantitative maps will be generated using Liver MultiScan software (Perspectum, UK) with operators blinded to patient status. T1 measurements will be adjusted for the iron level to give iron-corrected T1 maps (cT1). Reference ranges for cT1 have been defined in the general population. PDFF maps of the liver will be calculated using MRI multi-echo and spoiled-gradient-echo acquisition. No intravenous contrast agents will be used in Liver MultiScan maps and the total scan duration will be approximately 30 minutes.

All Listed Sponsors
collaborator

Fundacao Champalimaud

OTHER

lead

University Hospital Heidelberg

OTHER

NCT06181318 - Quantitative MRI and Outcomes of Liver Resection | Biotech Hunter | Biotech Hunter